Major Indexes

My Watchlist Items

Biophytis SA American Depositary Share (BPTS)
   13   0(0%)
Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD). Its second drug candidate, Macuneos (BIO201), is an orally administered small molecule in development for the treatment of retinal diseases, including dry ager elated macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101). The company was founded in 2006 and is headquartered in Paris, France.
TitleNamePayCurrency PayGenderYear BornTitle Since
Financial Controller Ms. _ Teylan N/A USD female N/A N/A
Chief Medical Officer Dr. Samuel Agus N/A USD N/A N/A
Scientific Advisor & Member of Scientific Advisory Board Dr. Rene Lafont N/A USD N/A N/A
Chief Scientific Officer Dr. Pierre J. Dilda N/A USD N/A N/A
Chief Operating Officer Mr. Waly Dioh N/A USD male N/A N/A
Chief Financial Officer Ms. Evelyne Nguyen N/A USD female N/A N/A
Chairman & Chief Executive Officer Mr. Stanislas Veillet 446170 USD male 1966 N/A
SymbolDateRatingRating Score Rating Details
HolderSharesDate ReportedChange
HolderSharesDate ReportedWeight Percent
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
SymbolDatePeriodDownload XLSX File
BPTS 2020 Q4 Download XLSX File


Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated

Company Profile

Company Name Biophytis SA American Depositary Share
Symbol BPTS
Currency USD
Price 13
Exchange Name Nasdaq Global Select (NASDAQ)
Industry Biotechnology
CEO Mr. Stanislas Veillet
Sector Healthcare
Country FR
Full Time Employees 25
Phone 33 1 44 27 23 00
Address Sorbonne Universit√©
City Paris